BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 11709286)

  • 1. Pathogenesis of mousepox in H-2(d) mice: evidence for MHC class I-restricted CD8(+) and MHC class II-restricted CD4(+) CTL antiviral activity in the lymph nodes, spleen and skin, but not in the conjunctivae.
    Cespedes IS; Toka FN; Schollenberger A; Gieryńska M; Niemiałtowski M
    Microbes Infect; 2001 Nov; 3(13):1063-72. PubMed ID: 11709286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of Antiviral Cytotoxic CD4 T Cell Differentiation.
    Knudson CJ; Férez M; Alves-Peixoto P; Erkes DA; Melo-Silva CR; Tang L; Snyder CM; Sigal LJ
    J Virol; 2021 Sep; 95(19):e0056621. PubMed ID: 34260270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection.
    Karupiah G; Buller RM; Van Rooijen N; Duarte CJ; Chen J
    J Virol; 1996 Dec; 70(12):8301-9. PubMed ID: 8970949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homing studies on distribution of ectromelia (mousepox) virus-specific T cells adoptively transferred into syngeneic H-2d mice: paradigm of lymphocyte migration.
    Gieryńska M; Toka FN; Cespedes IS; Schollenberger A; Malicka E; Popis A; Niemiałtowski MG
    Viral Immunol; 2000; 13(1):107-23. PubMed ID: 10733173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta 2-microglobulin-deficient mice demonstrate class II MHC restricted anti-viral CD4+ but not CD8+ CTL against influenza-sensitized autologous splenocytes.
    Taylor SF; Bender BS
    Immunol Lett; 1995 May; 46(1-2):67-73. PubMed ID: 7590931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient mice.
    Muller D; Koller BH; Whitton JL; LaPan KE; Brigman KK; Frelinger JA
    Science; 1992 Mar; 255(5051):1576-8. PubMed ID: 1347959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
    Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
    Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential susceptibility of cells expressing allogeneic MHC or viral antigen to killing by antigen-specific CTL.
    Lee K; Takenaka H; Yoneda Y; Goto T; Sano K; Nakanishi M; Eguchi A; Okada M; Tashiro J; Sakurai K; Kubota T; Yoshida R
    Microbiol Immunol; 2004; 48(1):15-25. PubMed ID: 14734854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4-negative cytotoxic T cells with a T cell receptor alpha/beta intermediate expression in CD8-deficient mice.
    Dalloul AH; Ngo K; Fung-Leung WP
    Eur J Immunol; 1996 Jan; 26(1):213-8. PubMed ID: 8566069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of MHC class II-restricted cytotoxic T lymphocytes in mice against herpes simplex virus.
    Kolaitis G; Doymaz M; Rouse BT
    Immunology; 1990 Sep; 71(1):101-6. PubMed ID: 2210799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
    Browning MJ; Huang AS; Reiss CS
    J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of allo-class II MHC-specific Th2 cells on the generation of CD4 and CD8 cytotoxic T cells to associated class I and class II MHC alloantigen.
    Wood PJ; Cossens IA
    Clin Exp Immunol; 1995 May; 100(2):359-65. PubMed ID: 7743677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
    Homma S; Komita H; Sagawa Y; Ohno T; Toda G
    Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T lymphocyte response to herpes simplex virus type 1 is composed of both CD8+ and CD4+ T cell phenotypes in acute and memory states.
    Niemiałtowski MG; Rouse BT
    Arch Immunol Ther Exp (Warsz); 1994; 42(4):319-24. PubMed ID: 7487374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
    Rock KL; Clark K
    J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions.
    Asnagli H; Schmitt-Verhulst AM; Guimezanes A
    J Immunol; 1997 May; 158(10):4533-42. PubMed ID: 9144464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rescue of cytotoxic function in the CD8alpha knockout mouse by removal of MHC class II.
    Riddle DS; Miller PJ; Vincent BG; Kepler TB; Maile R; Frelinger JA; Collins EJ
    Eur J Immunol; 2008 Jun; 38(6):1511-21. PubMed ID: 18465769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
    Nahill SR; Welsh RM
    J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class I-restricted determinants on the glutamic acid decarboxylase 65 molecule induce spontaneous CTL activity.
    Quinn A; McInerney MF; Sercarz EE
    J Immunol; 2001 Aug; 167(3):1748-57. PubMed ID: 11466400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.